Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Todd Daugherty (NPI 1639390776)

Field	Value
Entity Type	Individual
Organization	Todd Daugherty
Address	168 Maple Street
City	Henniker
State	NH
ZIP	03242
Taxonomy	Rheumatology Physician
NPI Enumerated	May 2, 2007

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

This provider is effectively a single-payer Medicare practice: lifetime Medicare revenue is $1.1M and there is no Medicaid billing on file, indicating Medicare constitutes the entirety of reported public-payer activity. The absence of Medicaid claims suggests payer mix is heavily weighted toward Medicare beneficiaries or services billed under Medicare coverage.

Revenue is highly concentrated in a small set of J-codes: the precomputed top 3 Medicare codes by revenue account for 82.8% of total Medicare revenue, signaling reliance on a few high-cost drug administrations rather than broad E/M office visit volume. This concentration implies the practice’s financial performance is sensitive to utilization or pricing changes for those specific biologic therapies.

The code mix and descriptions indicate a biologics/infusion-focused rheumatology operation: top codes are J9312 (rituximab), J0129 (abatacept), and J3262 (tocilizumab), which together drive the majority of revenue and reflect in-office administration of injectable biologic therapies and infusion services rather than primarily office-based evaluation and management. The presence of infusion-related add-on codes such as 96415 and chemotherapy administration codes (96413, 96401) further supports an infusion suite or infusion-capable clinic workflow.

J9312 (rituximab) is a notable volume outlier for the practice: it generated $397.8K and represents 34.5% of this provider’s Medicare revenue, and the provider ranks #19 of 317 nationally (94th percentile), described in the source as notably above typical national volume. This ranking positions the provider as a high-volume national participant specifically for rituximab administrations compared with peers.

J0129 (abatacept) and J3262 (tocilizumab) together comprise large shares of revenue ($302.6K and $253.8K respectively) and rank more modestly versus national peers (J0129 at the 55th percentile, J3262 at the 64th percentile). These volumes are described as typical or unremarkable nationally, suggesting the provider’s standout competitive edge is concentrated in rituximab rather than across all biologics.

While some chemotherapy/infusion procedure codes appear on the profile (96413, 96401, 96415), their dollar contributions are much smaller (for example, 96413 accounts for $44.5K or 3.9% of Medicare revenue). This pattern suggests ancillary infusion or chemotherapy-capable billing exists but is not a primary revenue driver relative to the biologic J-code portfolio.

Tenure is long-standing: the provider’s NPI was enumerated on 2007-05-02 (~19 years ago), indicating nearly two decades in the Medicare billing system. This longevity supports experience delivering the specific infusion services reflected in the billing mix and likely established referral relationships for biologic therapy administration.

Competitive posture is mixed: the provider is a dominant national-level participant for J9312 (rituximab) but is a modest-to-typical participant for other top biologic codes (J0129 and J3262). Overall, the practice appears to compete primarily as a high-volume rituximab infusion site while maintaining typical volumes for other biologic infusions nationally.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9312	Injection, rituximab, 10 mg	7,650	$50	$397.8K
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	8,900	$30	$302.6K
J3262	Injection, tocilizumab, 1 mg	50,760	$10	$253.8K
J1602	Injection, golimumab, 1 mg, for intravenous use	7,700	$10	$84.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	450	$100	$44.5K
J0897	Injection, denosumab, 1 mg	1,800	$20	$32.4K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	140	$130	$18.8K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	70	$100	$7.1K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	80	$60	$4.5K
96415	In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the…	200	$20	$4.3K

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Todd Daugherty — 3 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9312	1	10	7,650	$50	$397K
J0129	1	10	7,860	$30	$264.8K
J3262	1	10	50,760	$1	$235.7K
J1602	1	10	7,700	$10	$81.4K
J0897	16	20	2,760	$20	$75.4K
96413	1	20	140	$100	$15.8K
99214	1,903	3,150	110	$80	$13.2K
99215	106	1,080	40	$110	$6.8K
96401	2	10	70	$50	$5.1K
96415	1	20	50	$20	$1.4K

Showing 1–10 of 12

Related Providers

Other providers that share a Tax Identification Number (TIN) with Todd Daugherty, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Catholic Medical Center	NH	General Acute Care Hospital	$0	$19.8M
Appledore Medical Group, Inc	NH	Internal Medicine Physician	$0	$1.4M
Catholic Healthcare Trust	NH	Federally Qualified Health Center (FQHC)	$0	$1.3M
Ayobami Ojutalayo	MA	Family Medicine Physician	$521.7K	$1.6K
Catholic Medical Center	NH	Cardiovascular Disease Physician	$0	$489.4K
Catholic Medical Center	NH	General Acute Care Hospital	$0	$472.3K
Cmc D/b/a Urgent Care At Bedford Medical Park	NH	Urgent Care Clinic/Center	$0	$306.3K
Rajesh Mohan	NJ	Cardiovascular Disease Physician	$301.9K	$0
Dingxin Qin	NH	Clinical Cardiac Electrophysiology Physician	$221.1K	$0
Frank Jung	WI	Cardiovascular Disease Physician	$215.5K	$360

Nearby Providers

Other providers in the same ZIP code as Todd Daugherty, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Montshire Henniker PC	NH	Pediatric Dentistry	$0	$334.4K
Weare Schooldistrict	NH	Local Education Agency (LEA)	$0	$146.4K
John Stark School District	NH	Local Education Agency (LEA)	$0	$122.6K
Taylor Kirkpatrick	NH	Physician Assistant	$73.4K	$0
Henniker School District	NH	Local Education Agency (LEA)	$0	$66.3K
Eric Geaumont	NH	Counselor	$0	$62.9K
Patricia Winship	NH	Physical Therapist	$49.7K	$0

Todd Daugherty — Billing Profile & Reimbursement Data

Sign up for Todd Daugherty — Billing Profile & Reimbursement Data policy alerts

Todd Daugherty — Billing Profile & Reimbursement Data

Sign up for Todd Daugherty — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References